Taken together, C5aR1 deficiency prevents the progression of NASH by inhibiting the Toll-like receptor signaling pathway, promoting the differentiation of macrophage M2 phenotype and mediating the AKT signaling pathway. Here, C5AR1 is linked to metabolic dysfunction-associated steatohepatitis.